Aug 07, 2017 - The generic drugmaker lost 20% of its market cap last Thursday after a quarterly report that was heavy on bearish news.
Aug 07, 2017 - teva cut its dividend while its payout ratio indicates that this was unnecessary.This indicates that management sees more trouble down the road.This could provide an extra incentive for Allergan to se
Sep 11, 2017 - Teva Pharmaceutical Industries (NYSE:TEVA) inks an agreement with CooperSurgical to sell PARAGARD (intrauterine copper contraceptive) for $1.1B in cash. The deal includes Teva's manufacturing site in
Sep 12, 2017 - Teva closed 19% higher following the announcement of an industry veteran, Kare Schultz, as the incoming president and chief executive officer.The share price continued its march upwards the next day a
Dec 15, 2017 - Goldman Sachs raises its rating to buy from neutral for the generic drugmaker.
May 12, 2017 - Teva's Women's Health operations and its European oncology and pain divisions appear to be on the chopping block.
Jun 14, 2017 -
On CNBC's "Mad Money", Jim Cramer said that Under Armour Inc (NYSE: UAA) had a nice move higher and it could pull back a bit. He thinks the apparel sector isn't that bad.
Jun 09, 2017 - In the latest step toward remaking the company, Teva Pharmaceutical (NYSE:TEVA) will seek to overhaul its board by nominating four new directors.Among their first orders of business would be picking a
May 10, 2017 - From Copaxone's patents to its $35.8 billion in debt, shareholders have questions and we want answers.
Jun 06, 2017 - Teva's rough year continues to get worse. Is there light at the end of the tunnel?